Inhaler Devices for Patients with COPD
- 28 March 2013
- journal article
- review article
- Published by Taylor & Francis Ltd in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 10 (4), 523-535
- https://doi.org/10.3109/15412555.2012.761960
Abstract
Chronic obstructive pulmonary disease (COPD) continues to be associated with increased morbidity and mortality risk in spite of updated guidelines and a better understanding of this condition. Progressive airflow limitation and resultant hyperinflation—the respiratory hallmarks of this complex and often under-diagnosed disease—can be treated with pharmacotherapies emitted via nebulizers, pressurized metered-dose inhalers, dry powder inhalers, or a Soft Mist inhaler. Pharmaceutical company proprietary issues, technological innovations, and societal pressure have expanded the list of available inhalers, with a limited range of medications available for any one device. Each device has different operating and maintenance instructions, and successful use of a given drug/device combination requires that patients understand, maintain, and use each of their devices properly in order to ensure consistent and optimal pulmonary drug delivery. Clinicians are faced with a range of physical and psychosocial issues unique to each patient with COPD that must be overcome in order to match a suitable inhaler to the individual. Improved drug delivery afforded by next-generation inhalers, coupled with an awareness of device-specific and patient-specific variables affecting inhaler use, may improve clinical outcomes in the treatment of COPD.Keywords
This publication has 91 references indexed in Scilit:
- Misuse of Respiratory Inhalers in Hospitalized Patients with Asthma or COPDJournal of General Internal Medicine, 2011
- Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD PatientsJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2010
- Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trialThe Lancet, 2009
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary DiseaseNew England Journal of Medicine, 2008
- Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2008
- The rejuvenated pressurised metered dose inhalerExpert Opinion on Drug Delivery, 2007
- How Do Patients Determine That Their Metered-Dose Inhaler Is Empty?Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2004
- A Review of Ipratropium Bromide/Fenoterol Hydrobromide (Berodual??) Delivered Via Respimat?? Soft Mist??? Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary DiseaseDrugs, 2004
- The misconception of using floating patterns as an accurate means of measuring the contents of metered-dose inhaler devicesAnnals of Allergy, Asthma & Immunology, 2001
- Effectiveness and Acceptability of a Domiciliary Multidrug Inhalation Treatment in Elderly Patients with Chronic Airflow Obstruction: Metered Dose Inhaler Versus Jet NebulizerJournal of Aerosol Medicine, 2000